These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 16829540)

  • 21. Obligatory role of intraluminal O2- in acute endothelin-1 and angiotensin II signaling to mediate endothelial dysfunction and MAPK activation in guinea-pig hearts.
    Wojtera E; Konior A; Fedoryszak-Kuśka N; Beręsewicz A
    Int J Mol Sci; 2014 Oct; 15(11):19417-43. PubMed ID: 25350109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A role for pericytes in coronary no-reflow.
    O'Farrell FM; Attwell D
    Nat Rev Cardiol; 2014 Jul; 11(7):427-32. PubMed ID: 24776704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of D-dimer level on postinterventional coronary flow and in-hospital MACE in ST-segment elevation myocardial infarction.
    Sarli B; Akpek M; Baktir AO; Sahin O; Saglam H; Arinc H; Odabasi H; Dogan S; Kurtul S; Dogan Y; Kaya MG
    Herz; 2015 May; 40(3):507-13. PubMed ID: 24441391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. No-reflow reversibility: a study based on serial assessment of multiple biomarkers.
    Niccoli G; Fracassi F; Cosentino N; Falcioni E; Roberto M; De Luca G; Leone AM; Burzotta F; Porto I; Trani C; Severino A; Crea F
    J Cardiovasc Transl Res; 2013 Oct; 6(5):798-807. PubMed ID: 24008841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peripheral cardiac sympathetic hyperactivity in cardiovascular disease: role of neuropeptides.
    Shanks J; Herring N
    Am J Physiol Regul Integr Comp Physiol; 2013 Dec; 305(12):R1411-20. PubMed ID: 24005254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of statin pretreatment on myocardial perfusion in patients undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis.
    Lyu T; Zhao Y; Zhang T; Zhou W; Yang F; He Q; Yuan A; Yao T; Pu J; He B
    Clin Cardiol; 2013 Sep; 36(9):E17-24. PubMed ID: 23893797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship of plasma neuropeptide Y with angiographic, electrocardiographic and coronary physiology indices of reperfusion during ST elevation myocardial infarction.
    Cuculi F; Herring N; De Caterina AR; Banning AP; Prendergast BD; Forfar JC; Choudhury RP; Channon KM; Kharbanda RK
    Heart; 2013 Aug; 99(16):1198-203. PubMed ID: 23403409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcium antagonists in myocardial ischemia/reperfusion--update 2012.
    Kleinbongard P; Baars T; Heusch G
    Wien Med Wochenschr; 2012 Jul; 162(13-14):302-10. PubMed ID: 22695811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in left ventricular ejection fraction and coronary flow reserve after coronary microembolization.
    Ma J; Qian J; Ge J; Zeng X; Sun A; Chang S; Chen Z; Zou Y
    Arch Med Sci; 2012 Feb; 8(1):63-9. PubMed ID: 22457677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased plasma levels of endothelin-1 and urotensin-II in patients with coronary heart disease.
    Chai SB; Li XM; Pang YZ; Qi YF; Tang CS
    Heart Vessels; 2010 Mar; 25(2):138-43. PubMed ID: 20339975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the yeast tricalbins: membrane-bound multi-C2-domain proteins that form complexes involved in membrane trafficking.
    Creutz CE; Snyder SL; Schulz TA
    Cell Mol Life Sci; 2004 May; 61(10):1208-20. PubMed ID: 15141306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Baseline systemic inflammatory status and no-reflow phenomenon after percutaneous coronary angioplasty for acute myocardial infarction.
    Niccoli G; Lanza GA; Spaziani C; Altamura L; Romagnoli E; Leone AM; Fusco B; Trani C; Burzotta F; Mazzari MA; Mongiardo R; Biasucci LM; Rebuzzi AG; Crea F
    Int J Cardiol; 2007 May; 117(3):306-11. PubMed ID: 16859772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New strategies for the management of no-reflow after primary percutaneous coronary intervention.
    Niccoli G; Cosentino N; Spaziani C; Minelli S; Fracassi F; Crea F
    Expert Rev Cardiovasc Ther; 2011 May; 9(5):615-30. PubMed ID: 21615325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanical revascularization after acute myocardial infarction.
    Silva JM
    Rev Port Cardiol; 1995 Jun; 14(6):499-502. PubMed ID: 7662390
    [No Abstract]   [Full Text] [Related]  

  • 35. Endothelin-1 and acute myocardial infarction: a no-reflow mediator after successful percutaneous myocardial revascularization.
    Niccoli G; Lanza GA; Shaw S; Romagnoli E; Gioia D; Burzotta F; Trani C; Mazzari MA; Mongiardo R; De Vita M; Rebuzzi AG; Lüscher TF; Crea F
    Eur Heart J; 2006 Aug; 27(15):1793-8. PubMed ID: 16829540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endothelin-1 release in acute myocardial infarction as a predictor of long-term prognosis and no-reflow assessed by contrast-enhanced magnetic resonance imaging.
    Eitel I; Nowak M; Stehl C; Adams V; Fuernau G; Hildebrand L; Desch S; Schuler G; Thiele H
    Am Heart J; 2010 May; 159(5):882-90. PubMed ID: 20435200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma levels of thromboxane A2 on admission are associated with no-reflow after primary percutaneous coronary intervention.
    Niccoli G; Giubilato S; Russo E; Spaziani C; Leo A; Porto I; Leone AM; Burzotta F; Riondino S; Pulcinelli F; Biasucci LM; Crea F
    Eur Heart J; 2008 Aug; 29(15):1843-50. PubMed ID: 18617477
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.